Perspective Therapeutics, Inc. (CATX)
2.66
-0.05
(-1.84%)
USD |
NYAM |
Oct 09, 16:00
2.645
-0.02
(-0.56%)
After-Hours: 20:00
Perspective Therapeutics Cash from Operations (Quarterly) : -20.65M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -20.65M |
| March 31, 2026 | -31.47M |
| December 31, 2025 | -24.66M |
| September 30, 2025 | -16.29M |
| June 30, 2025 | -19.95M |
| March 31, 2025 | -21.58M |
| December 31, 2024 | -26.61M |
| September 30, 2024 | 3.366M |
| June 30, 2024 | -8.902M |
| March 31, 2024 | 13.85M |
| December 31, 2023 | |
| September 30, 2023 | -10.11M |
| June 30, 2023 | -8.072M |
| March 31, 2023 | -9.723M |
| June 30, 2022 | -2.891M |
| March 31, 2022 | -1.422M |
| December 31, 2021 | -1.313M |
| September 30, 2021 | -2.084M |
| June 30, 2021 | -1.118M |
| March 31, 2021 | -0.621M |
| December 31, 2020 | -0.76M |
| September 30, 2020 | -0.338M |
| June 30, 2020 | -0.848M |
| March 31, 2020 | -0.862M |
| December 31, 2019 | -1.278M |
| Date | Value |
|---|---|
| September 30, 2019 | -0.653M |
| June 30, 2019 | -0.985M |
| March 31, 2019 | -1.338M |
| December 31, 2018 | -1.114M |
| September 30, 2018 | -1.612M |
| June 30, 2018 | -1.448M |
| March 31, 2018 | -1.08M |
| December 31, 2017 | -1.523M |
| September 30, 2017 | -1.661M |
| June 30, 2017 | -1.213M |
| March 31, 2017 | -1.485M |
| December 31, 2016 | -1.661M |
| September 30, 2016 | -1.353M |
| June 30, 2016 | -1.208M |
| March 31, 2016 | -0.7558M |
| December 31, 2015 | -0.8103M |
| September 30, 2015 | -1.110M |
| June 30, 2015 | -0.6294M |
| March 31, 2015 | -1.135M |
| December 31, 2014 | -0.6144M |
| September 30, 2014 | -1.143M |
| June 30, 2014 | -0.989M |
| March 31, 2014 | -0.5012M |
| December 31, 2013 | -0.846M |
| September 30, 2013 | -0.892M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | -0.684M |
| MiMedx Group, Inc. | -10.03M |
| ABVC BioPharma, Inc. | -0.2444M |
| Enovis Corp. | 75.03M |
| Edwards Lifesciences Corp. | 651.90M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 15.02M |
| Cash from Financing (Quarterly) | 0.147M |
| Free Cash Flow | -121.38M |
| Free Cash Flow Per Share (Quarterly) | -0.289 |
| Free Cash Flow to Equity (Quarterly) | -34.60M |
| Free Cash Flow to Firm (Quarterly) | -34.80M |
| Free Cash Flow Yield | -48.95% |